Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PB-201 vs Vildagliptin in Treatment-naive T2DM
NCT05102149Phase 3Unknown
- Sponsor
- PegBio
- Start
- Sep 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of nerigliatin in type 2 diabetes mellitus (T2DM), sponsored by PegBio. Status: unknown.
02
Drugs
nerigliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05102149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05102149.